N/A N=473 Improving Medication Adherence in the Alabama Black Belt
Diabetes Mellitus · Medication Adherence
Primary: Change in Self Reported Medication Adherence — 0.78; 0.74; 0.53; 0.62 Scores on a scale — p=0.22
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=42 A Study of LY900014 in a Medtronic Pump
Type1 Diabetes Mellitus
Primary: Percentage of Time With Sensor Glucose Values Between 70 and 180 Milligrams Per Deciliter (mg/dL) (24-Hour) — 76.98; 77.84 Percentage of Time — p=0.339
Phase 2 N=22 Pharmacokinetics, Efficacy, and Safety of Human Plasma-Derived Fibrinogen (FIB Grifols) in Participants With Congenital Afibrinogenemia
Congenital Afibrinogenemia
Primary: Area Under the Plasma Fibrinogen Concentration-time Curve (AUC) From Time Zero to 14 Days (AUC0-14days) of FIB Grifols Determined by Clauss Method, Dose Normalized to 70…
N/A N=69 The Effects of the Dietary Supplement CardioFlex Q10 on Reducing Cardiovascular Disease Risk Factors in Adults
Cardiovascular Diseases · Cardiovascular Abnormalities · Heart Attack
Primary: Change From Baseline of Total Cholesterol After 90 Days — -0.57; -1.09 mmol/L — p=0.042
N/A N=403 Antimicrobial Stewardship Program for Clostridium Difficile Infection.
Clostridium Difficile · Enterocolitis, Pseudomembranous
Primary: Number of Participants With Clostridium Difficile Infection Recurrence. — 34; 21 Participants — p=0.56
Phase 4 N=36 Foot and Ankle Clinic Application for Liposomal Related Anesthetic
Ankle Arthrodesis · Hindfoot Arthrodesis · Tibitalocalceal Arthrodesis
Primary: Amount of Narcotic Use — 236.68 mg
N/A N=20 RF Rejuvenation for Pelvic Floor and Vagina
Symptoms Associated With Pelvic Floor Weakness
Primary: Effect of RF on Pelvic Floor Measured by Intentional Muscle Contraction Using Biofeedback EMS — 13.13 mV
Phase 4 N=1,044 Polyethylene Glycol Versus Low Volume Solutions Prior to Colonoscopy
Colonoscopy
Primary: Quality of Bowel Preparation Using the Aronchick Scale ( Score 1+2) — 110; 145; 100; 134 Participants
N/A N=130 A Comparison of Pregabalin (Lyrica®) to Placebo in Pain Relief After Photorefractive Keratectomy (PRK) Surgery
Postoperative Pain
Primary: Clinical Efficacy — 0.89; 1.33; 7.56; 10.34 units on a scale — p=0.180
Phase 2 N=416 Study Investigating the Effect of 4 Doses of RPL554 Given in Addition to Tiotropium to Patients With COPD
COPD
Primary: Least Square (LS) Mean Change From Baseline Forced Expiratory Volume in 1 Second (FEV1) to Peak FEV1 at Week 4 — 0.1963; 0.2100; 0.2260; 0.2431 liters — p=0.0008
Phase 4 N=92 Pharmacogenomics and Post-Operative Nausea and Vomiting
Postoperative Nausea
Primary: Episodes of Postoperative Nausea — 0; 16 episodes
Phase 2 N=127 A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
Gout
Primary: Proportion of Subjects Achieving Serum Uric Acid Concentration <6.0 mg/dL — 33; 43 Participants
N/A N=3,889 Improve Sudden Cardiac Arrest Study
Sudden Cardiac Arrest · Ventricular Arrythmia
Primary: Time to the First Occurrence of a Ventricular Arrhythmia — 32.5; 18.3 Estimated 24-Month VT-VF Pct of Patients
Phase 2 N=66 A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)
Lymphoma
Primary: BICR-Assessed Objective Response Rate (ORR) — 6.4; 26.3 Percentage of participants
N/A N=63 Predictive Value of the Active Straight Leg Raise on the Efficacy of a SJB in Posterior PGP During Pregnancy
Pelvic Girdle Pain
Primary: Change From Baseline in Functioning on the Active Straight Leg Rise (ASLR) Scale at 4 Weeks. — 4.87; 2.92 score on a scale — p=<.001